{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:36:03Z","timestamp":1789983363244,"version":"4.0.1"},"reference-count":41,"publisher":"Bioscientifica","issue":"4","content-domain":{"domain":["erc.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1,12]]},"abstract":"<jats:p>Precision medicine (PM) aims to maximize the risk\u2013benefit balance of medical decisions by integrating individual patient and disease characteristics. This approach is gaining increasing recognition from clinicians, healthcare systems, pharmaceutical companies, patients, and governments. Nuclear medicine plays a critical role in PM by its virtue of providing critical information at every step of disease management, digital markers, and companion diagnostics\/therapeutics. It is anticipated that technological breakthroughs and new tracers will continue to position nuclear medicine among the significant players in PM.<\/jats:p>","DOI":"10.1530\/erc-22-0375","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T12:47:30Z","timestamp":1673527650000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":8,"title":["Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine"],"prefix":"10.1530","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-7600","authenticated-orcid":true,"given":"David","family":"Ta\u00efeb","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Fargette","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jha","sequence":"additional","affiliation":[{"name":"Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3541-3767","authenticated-orcid":true,"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[{"name":"Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1176","article-title":"Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation","volume":"105","author":"Abdul Sater","year":"2020","unstructured":"Abdul Sater ZJha AHamimi AMandl AHartley IRGubbi SPatel MGonzales MTaieb DCivelek AC2020Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation. Journal of Clinical Endocrinology and Metabolism1051176\u20131185. (https:\/\/doi.org\/10.1210\/clinem\/dgz314)"},{"key":"bib2","series-title":"Cancers (Basel)","first-page":"2424","article-title":"Usefulness of FDG-PET\/CT-based radiomics for the characterization and genetic orientation of pheochromocytomas before surgery","volume":"12","author":"Ansquer","year":"2020","unstructured":"Ansquer CDrui DMirallie ERenaudin-Autain KDenis AGimenez-Roqueplo APLeux CToulgoat FKraeber-Bodere FCarlier T2020Usefulness of FDG-PET\/CT-based radiomics for the characterization and genetic orientation of pheochromocytomas before surgery. Cancers (Basel)122424. (https:\/\/doi.org\/10.3390\/cancers12092424)"},{"key":"bib3","series-title":"Medical and Biological Engineering and Computing","first-page":"103","article-title":"Determination of the unmetabolised 18F-FDG fraction by using an extension of simplified kinetic analysis method: clinical evaluation in paragangliomas","volume":"54","author":"Barbolosi","year":"2016","unstructured":"Barbolosi DHapdey SBattini SFaivre CMancini JPacak KFarman-Ara BTaieb D2016Determination of the unmetabolised 18F-FDG fraction by using an extension of simplified kinetic analysis method: clinical evaluation in paragangliomas. Medical and Biological Engineering and Computing54103\u2013111. (https:\/\/doi.org\/10.1007\/s11517-015-1318-3)"},{"key":"bib4","series-title":"European Journal of Nuclear Medicine and Molecular Imaging","first-page":"1113","article-title":"Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms","volume":"49","author":"Borgna","year":"2022","unstructured":"Borgna FHaller SRodriguez JMMGinj MGrundler PVZeevaart JRKoster USchibli Rvan der Meulen NPMuller C2022Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms. European Journal of Nuclear Medicine and Molecular Imaging491113\u20131126. (https:\/\/doi.org\/10.1007\/s00259-021-05564-0)"},{"key":"bib5","series-title":"JCO Precision Oncology","first-page":"1","article-title":"Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumours into clinical utility","volume":"2","author":"Casey","year":"2018","unstructured":"Casey RTMcLean MAMadhu BChallis BGTen Hoopen RRoberts TClark GRPittfield DSimpson HLBulusu VR2018Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumours into clinical utility. JCO Precision Oncology21\u201312. (https:\/\/doi.org\/10.1200\/PO.17.00191)"},{"key":"bib6","series-title":"Journal of Nuclear Medicine","first-page":"1326","article-title":"Targeted alpha-emitter therapy with 212Pb-DOTAMTATE for the treatment of metastatic sstr-expressing neuroendocrine tumors: first-in-humans dose-escalation clinical trial","volume":"63","author":"Delpassand","year":"2022","unstructured":"Delpassand ESTworowska IEsfandiari RTorgue JHurt JShafie ANunez R2022Targeted alpha-emitter therapy with 212Pb-DOTAMTATE for the treatment of metastatic sstr-expressing neuroendocrine tumors: first-in-humans dose-escalation clinical trial. Journal of Nuclear Medicine631326\u20131333. (https:\/\/doi.org\/10.2967\/jnumed.121.263230)"},{"key":"bib7","series-title":"Cancers (Basel)","first-page":"1172","article-title":"Radiolabeled somatostatin analogs-A continuously evolving class of radiopharmaceuticals","volume":"14","author":"Fani","year":"2022","unstructured":"Fani MMansi RNicolas GP & Wild D2022Radiolabeled somatostatin analogs-A continuously evolving class of radiopharmaceuticals. Cancers (Basel)141172. (https:\/\/doi.org\/10.3390\/cancers14051172)"},{"key":"bib8","series-title":"Journal of Nuclear Medicine","first-page":"720","article-title":"CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: a phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody","volume":"63","author":"Farwell","year":"2022","unstructured":"Farwell MDGamache RFBabazada HHellmann MDHarding JJKorn RMascioni ALe WWilson IGordon MS2022CD8-targeted PET imaging of tumor-infiltrating T cells in patients with cancer: a phase I first-in-humans study of 89Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody. Journal of Nuclear Medicine63720\u2013726. (https:\/\/doi.org\/10.2967\/jnumed.121.262485)"},{"key":"bib9","series-title":"Journal of Nuclear Medicine","first-page":"1749","article-title":"The evolving role of succinate in tumor metabolism: an 18F-FDG-based study","volume":"58","author":"Garrigue","year":"2017","unstructured":"Garrigue PBodin-Hullin ABalasse LFernandez SEssamet WDignat-George FPacak KGuillet BTaieb D2017The evolving role of succinate in tumor metabolism: an 18F-FDG-based study. Journal of Nuclear Medicine581749\u20131755. (https:\/\/doi.org\/10.2967\/jnumed.117.192674)"},{"key":"bib10","series-title":"Journal of Nuclear Medicine","first-page":"365","article-title":"Radiomics in PET\/CT: more than meets the eye?","volume":"58","author":"Hatt","year":"2017","unstructured":"Hatt MTixier FVisvikis DCheze Le Rest C2017Radiomics in PET\/CT: more than meets the eye?Journal of Nuclear Medicine58365\u2013366. (https:\/\/doi.org\/10.2967\/jnumed.116.184655)"},{"key":"bib11","series-title":"Cancer Imaging","article-title":"Will ultra-extended field-of-view scanners be an expensive folly or the next clinical standard for PET\/CT?","volume":"22","author":"Hicks","year":"2022","unstructured":"Hicks RJVan den Abbeele AD2022Will ultra-extended field-of-view scanners be an expensive folly or the next clinical standard for PET\/CT?Cancer Imaging22 49. (https:\/\/doi.org\/10.1186\/s40644-022-00486-y)"},{"key":"bib12","series-title":"Journal of Nuclear Medicine","first-page":"1455","article-title":"Quantification of PD-L1 expression with 18F-BMS-986192 PET\/CT in patients with advanced-stage non-small cell lung cancer","volume":"61","author":"Huisman","year":"2020","unstructured":"Huisman MCNiemeijer ANWindhorst ADSchuit RCLeung DHayes WPoot ABahce IRadonic TOprea-Lager DE2020Quantification of PD-L1 expression with 18F-BMS-986192 PET\/CT in patients with advanced-stage non-small cell lung cancer. Journal of Nuclear Medicine611455\u20131460. (https:\/\/doi.org\/10.2967\/jnumed.119.240895)"},{"key":"bib13","series-title":"Neoplasia","first-page":"55","article-title":"Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications","volume":"17","author":"Imperiale","year":"2015","unstructured":"Imperiale AMoussallieh FMRoche PBattini SCicek AESebag FBrunaud LBarlier AElbayed KLoundou A2015Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications. Neoplasia1755\u201365. (https:\/\/doi.org\/10.1016\/j.neo.2014.10.010)"},{"key":"bib14","series-title":"Disease Markers","article-title":"Expression of glutamine metabolism-related and amino acid transporter proteins in adrenal cortical neoplasms and pheochromocytomas","volume":"2021","author":"Kim","year":"2021","unstructured":"Kim HMKoo JS2021Expression of glutamine metabolism-related and amino acid transporter proteins in adrenal cortical neoplasms and pheochromocytomas. Disease Markers2021 8850990. (https:\/\/doi.org\/10.1155\/2021\/8850990)"},{"key":"bib15","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2801","article-title":"Succinate: a serum biomarker of SDHB-mutated paragangliomas and pheochromocytomas","volume":"107","author":"Lamy","year":"2022","unstructured":"Lamy CTissot HFaron MBaudin ELamartina LPradon CAl Ghuzlan ALeboulleux SPerfettini JLPaci A2022Succinate: a serum biomarker of SDHB-mutated paragangliomas and pheochromocytomas. Journal of Clinical Endocrinology and Metabolism1072801\u20132810. (https:\/\/doi.org\/10.1210\/clinem\/dgac474)"},{"key":"bib16","series-title":"Physics in Medicine and Biology","first-page":"21RM01","article-title":"Roadmap toward the 10 ps time-of-flight PET challenge","volume":"65","author":"Lecoq","year":"2020","unstructured":"Lecoq PMorel CPrior JOVisvikis DGundacker SAuffray EKrizan PTurtos RMThers DCharbon E2020Roadmap toward the 10 ps time-of-flight PET challenge. Physics in Medicine and Biology6521RM01. (https:\/\/doi.org\/10.1088\/1361-6560\/ab9500)"},{"key":"bib17","series-title":"Clinical Cancer Research","first-page":"1120","article-title":"In vivo detection of succinate by magnetic resonance spectroscopy as a hallmark of SDHx mutations in paraganglioma","volume":"22","author":"Lussey-Lepoutre","year":"2016","unstructured":"Lussey-Lepoutre CBellucci AMorin ABuffet AAmar LJanin MOttolenghi CZinzindohoue FAutret GBurnichon N2016In vivo detection of succinate by magnetic resonance spectroscopy as a hallmark of SDHx mutations in paraganglioma. Clinical Cancer Research221120\u20131129. (https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-1576)"},{"key":"bib18","series-title":"Nature Communications","article-title":"Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism","volume":"6","author":"Lussey-Lepoutre","year":"2015","unstructured":"Lussey-Lepoutre CHollinshead KELudwig CMenara MMorin ACastro-Vega LJParker SJJanin MMartinelli COttolenghi C2015Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism. Nature Communications6 8784. (https:\/\/doi.org\/10.1038\/ncomms9784)"},{"key":"bib19","series-title":"Journal of Nuclear Medicine","first-page":"899","article-title":"18F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: a pilot study","volume":"63","author":"Nienhuis","year":"2022","unstructured":"Nienhuis PHAntunes IFGlaudemans AWJMJalving MLeung DNoordzij WSlart RHJAde Vries EFJHospers GAP202218F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: a pilot study. Journal of Nuclear Medicine63899\u2013905. (https:\/\/doi.org\/10.2967\/jnumed.121.262368)"},{"key":"bib20","series-title":"European Radiology","first-page":"7227","article-title":"[18F]FDG-PET\/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas","volume":"32","author":"Noortman","year":"2022","unstructured":"Noortman WAVriens Dde Geus-Oei LFSlump CHAarntzen EHvan Berkel ATimmers HJLMvan Velden FHP2022[18F]FDG-PET\/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas. European Radiology327227\u20137236. (https:\/\/doi.org\/10.1007\/s00330-022-09034-5)"},{"key":"bib21","series-title":"Journal of Nuclear Medicine","first-page":"512","article-title":"First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting","volume":"61","author":"Pandit-Taskar","year":"2020","unstructured":"Pandit-Taskar NPostow MAHellmann MDHarding JJBarker CAO'Donoghue JAZiolkowska MRuan SLyashchenko SKTsai F2020First-in-humans imaging with 89Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting. Journal of Nuclear Medicine61512\u2013519. (https:\/\/doi.org\/10.2967\/jnumed.119.229781)"},{"key":"bib22","series-title":"Journal of Nuclear Medicine","first-page":"1228","article-title":"Synthesis and preclinical evaluation of a 68Ga-labeled adnectin, 68Ga-BMS-986192, as a PET agent for imaging PD-L1 expression","volume":"62","author":"Robu","year":"2021","unstructured":"Robu SRichter AGosmann DSeidl CLeung DHayes WCohen DMorin PDonnelly DJLipovsek D2021Synthesis and preclinical evaluation of a 68Ga-labeled adnectin, 68Ga-BMS-986192, as a PET agent for imaging PD-L1 expression. Journal of Nuclear Medicine621228\u20131234. (https:\/\/doi.org\/10.2967\/jnumed.120.258384)"},{"key":"bib23","series-title":"Nature","first-page":"577","article-title":"Automation: chemistry shoots for the moon","volume":"568","author":"Sanderson","year":"2019","unstructured":"Sanderson K2019Automation: chemistry shoots for the moon. Nature568577\u2013579. (https:\/\/doi.org\/10.1038\/d41586-019-01246-y)"},{"key":"bib24","series-title":"Cancers (Basel)","first-page":"599","article-title":"Glutaminases as a novel target for SDHB-associated pheochromocytomas\/paragangliomas","volume":"12","author":"Sarkadi","year":"2020","unstructured":"Sarkadi BMeszaros KKrencz ICanu LKrokker LZakarias SBarna GSebestyen APapay JHujber Z2020Glutaminases as a novel target for SDHB-associated pheochromocytomas\/paragangliomas. Cancers (Basel)12599. (https:\/\/doi.org\/10.3390\/cancers12030599)"},{"key":"bib25","series-title":"Journal of the National Cancer Institute","first-page":"djv287","article-title":"SDHB-deficient cancers: the role of mutations that impair iron sulfur cluster delivery","volume":"108","author":"Saxena","year":"2016","unstructured":"Saxena NMaio NCrooks DRRicketts CJYang YWei MHFan TWLane ANSourbier CSingh A2016SDHB-deficient cancers: the role of mutations that impair iron sulfur cluster delivery. Journal of the National Cancer Institute108djv287. (https:\/\/doi.org\/10.1093\/jnci\/djv287)"},{"key":"bib26","series-title":"Journal of Nuclear Medicine","first-page":"1839","article-title":"Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer 18F-BMS-986192","volume":"61","author":"Stutvoet","year":"2020","unstructured":"Stutvoet TSvan der Veen ELKol AAntunes IFde Vries EFJHospers GAPde Vries EGEde Jong S & Lub-de Hooge MN2020Molecular imaging of PD-L1 expression and dynamics with the adnectin-based PET tracer 18F-BMS-986192. Journal of Nuclear Medicine611839\u20131844. (https:\/\/doi.org\/10.2967\/jnumed.119.241364)"},{"key":"bib27","series-title":"International Journal of Molecular Sciences","first-page":"560","article-title":"Loss of SDHB induces a metabolic switch in the hPheo1 cell line toward enhanced OXPHOS","volume":"23","author":"Tabebi","year":"2022","unstructured":"Tabebi MKumar Dutta RSkoglund CSoderkvist P & Gimm O2022Loss of SDHB induces a metabolic switch in the hPheo1 cell line toward enhanced OXPHOS. International Journal of Molecular Sciences23560. (https:\/\/doi.org\/10.3390\/ijms23010560)"},{"key":"bib28","series-title":"European Journal of Nuclear Medicine and Molecular Imaging","first-page":"2112","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Taieb","year":"2019a","unstructured":"Taieb DHicks RJHindie EGuillet BAAvram AGhedini PTimmers HJScott ATElojeimy SRubello D2019aEuropean Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. European Journal of Nuclear Medicine and Molecular Imaging462112\u20132137. (https:\/\/doi.org\/10.1007\/s00259-019-04398-1)"},{"key":"bib29","series-title":"European Journal of Nuclear Medicine and Molecular Imaging","first-page":"391","article-title":"Radiopharmaceuticals in paraganglioma imaging: too many members on board?","volume":"43","author":"Taieb","year":"2016","unstructured":"Taieb DHicks RJPacak K2016Radiopharmaceuticals in paraganglioma imaging: too many members on board?European Journal of Nuclear Medicine and Molecular Imaging43391\u2013393. (https:\/\/doi.org\/10.1007\/s00259-015-3213-4)"},{"key":"bib30","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1574","article-title":"18F-FDOPA PET\/CT imaging of MAX-related pheochromocytoma","volume":"103","author":"Taieb","year":"2018","unstructured":"Taieb DJha AGuerin CPang YAdams KTChen CCRomanet PRoche PEssamet WLing A201818F-FDOPA PET\/CT imaging of MAX-related pheochromocytoma. Journal of Clinical Endocrinology and Metabolism1031574\u20131582. (https:\/\/doi.org\/10.1210\/jc.2017-02324)"},{"key":"bib31","series-title":"Endocrine-Related Cancer","first-page":"R627","article-title":"Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups","volume":"26","author":"Taieb","year":"2019b","unstructured":"Taieb DJha ATreglia GPacak K2019bMolecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups. Endocrine-Related Cancer26R627\u2013R652. (https:\/\/doi.org\/10.1530\/ERC-19-0165)"},{"key":"bib32","series-title":"Journal of Nuclear Medicine","first-page":"711","article-title":"18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?","volume":"50","author":"Taieb","year":"2009","unstructured":"Taieb DSebag FBarlier ATessonnier LPalazzo FFMorange INiccoli-Sire PFakhry NDe Micco CCammilleri S200918F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?Journal of Nuclear Medicine50711\u2013717. (https:\/\/doi.org\/10.2967\/jnumed.108.060731)"},{"key":"bib33","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"4757","article-title":"Comparison of 18F-fluoro-L-dopa, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","unstructured":"Timmers HJChen CCCarrasquillo JAWhatley MLing AHavekes BEisenhofer GMartiniova LAdams KT & Pacak K2009Comparison of 18F-fluoro-L-dopa, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. Journal of Clinical Endocrinology and Metabolism944757\u20134767. (https:\/\/doi.org\/10.1210\/jc.2009-1248)"},{"key":"bib34","series-title":"Journal of Clinical Oncology","first-page":"2262","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","author":"Timmers","year":"2007","unstructured":"Timmers HJKozupa AChen CCCarrasquillo JALing AEisenhofer GAdams KTSolis DLenders JWPacak K2007Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma. Journal of Clinical Oncology252262\u20132269. (https:\/\/doi.org\/10.1200\/JCO.2006.09.6297)"},{"key":"bib35","series-title":"Journal of Nuclear Medicine","first-page":"745","article-title":"Metabolic subtyping of pheochromocytoma and paraganglioma by 18F-FDG pharmacokinetics using dynamic PET\/CT scanning","volume":"60","author":"van Berkel","year":"2019","unstructured":"van Berkel AVriens DVisser EPJanssen MJRGotthardt MHermus ARMMGeus-Oei LFTimmers HJLM2019Metabolic subtyping of pheochromocytoma and paraganglioma by 18F-FDG pharmacokinetics using dynamic PET\/CT scanning. Journal of Nuclear Medicine60745\u2013751. (https:\/\/doi.org\/10.2967\/jnumed.118.216796)"},{"key":"bib36","series-title":"Endocrine-Related Cancer","first-page":"M1","article-title":"Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics","volume":"22","author":"Varoquaux","year":"2015","unstructured":"Varoquaux Ale Fur YImperiale AReyre AMontava MFakhry NNamer IJMoulin GPacak KGuye M2015Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics. Endocrine-Related Cancer22M1\u2013M8. (https:\/\/doi.org\/10.1530\/ERC-15-0246)"},{"key":"bib37","series-title":"Journal of Nuclear Medicine","first-page":"1154","article-title":"Kinetic modeling of (18)F-(2S,4R)4-Fluoroglutamine in mouse models of breast cancer to estimate glutamine pool size as an indicator of tumor glutamine metabolism","volume":"62","author":"Viswanath","year":"2021","unstructured":"Viswanath VZhou RLee HLi SCragin ADoot RKMankoff DAPantel AR2021Kinetic modeling of (18)F-(2S,4R)4-Fluoroglutamine in mouse models of breast cancer to estimate glutamine pool size as an indicator of tumor glutamine metabolism. Journal of Nuclear Medicine621154\u20131162. (https:\/\/doi.org\/10.2967\/jnumed.120.250977)"},{"key":"bib38","series-title":"European Journal of Nuclear Medicine and Molecular Imaging","first-page":"1595","article-title":"Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study","volume":"49","author":"Yadav","year":"2022","unstructured":"Yadav MPBallal SSahoo RKBal C2022Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging491595\u20131606. (https:\/\/doi.org\/10.1007\/s00259-021-05632-5)"},{"key":"bib39","series-title":"Endocrine-Related Cancer","first-page":"311","article-title":"Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations","volume":"15","author":"Zelinka","year":"2008","unstructured":"Zelinka TTimmers HJKozupa AChen CCCarrasquillo JAReynolds JCLing AEisenhofer GLazurova IAdams KT2008Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations. Endocrine-Related Cancer15311\u2013323. (https:\/\/doi.org\/10.1677\/ERC-07-0217)"},{"key":"bib40","series-title":"Journal of Nuclear Medicine","first-page":"1","article-title":"F-Fluciclovine PET imaging of glutaminase inhibition in breast cancer models","volume":"64","author":"Zhou","year":"2022","unstructured":"Zhou RChoi HCao JPantel AGupta MLee HMankoff D2022F-Fluciclovine PET imaging of glutaminase inhibition in breast cancer models. Journal of Nuclear Medicine64131\u2013136. (https:\/\/doi.org\/10.2967\/jnumed.122.264152)"},{"key":"bib41","series-title":"Cancer Research","first-page":"1476","article-title":"[18F](2S,4R)4-Fluoroglutamine PET detects glutamine pool size changes in triple-negative breast cancer in response to glutaminase inhibition","volume":"77","author":"Zhou","year":"2017","unstructured":"Zhou RPantel ARLi SLieberman BPPloessl KChoi HBlankemeyer ELee HKung HFMach RH2017[18F](2S,4R)4-Fluoroglutamine PET detects glutamine pool size changes in triple-negative breast cancer in response to glutaminase inhibition. Cancer Research771476\u20131484. (https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1945)"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/30\/4\/ERC-22-0375.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/30\/4\/ERC-22-0375.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/30\/4\/ERC-22-0375.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:56:28Z","timestamp":1784555788000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/erc\/article\/25732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":41,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/erc-22-0375","relation":{},"ISSN":["1351-0088","1479-6821"],"issn-type":[{"value":"1351-0088","type":"print"},{"value":"1479-6821","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}